This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lind, R. C. Articles by Gandolfi, A. J. Search for Related Content PubMed PubMed Citation Articles by Lind, R. C. Articles by Gandolfi, A. J. Social Bookmarking                         What's this?

Hepatoprotection by Dimethyl Sulfoxide. I. Protection When Given Twenty-Four Hours After Chloroform or Bromobenzene

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721

A. Jay Gandolfi

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, gandolfi@ pharmacy.arizona.edu.

Dimethyl sulfoxide (DMSO) has previously been reported to protect against hepatotoxicity resulting from chloroform (CHCl₃) or bromobenzene (BB) when given 10 hr after the toxicant. The object of these studies was to further demonstrate the latent protective ability of DMSO by administering it at a much later time (24 hr) following toxicant exposure. In addition, a more detailed evaluation of the lesions was performed to better characterize the lesion progression and resolution. Male Sprague-Dawley rats received a hepatotoxic oral dose of either CHCl₃ (1.0 ml/kg) or BB (0.5 ml/kg) and then received 2 ml/kg DMSO intraperitoneally 24 hr later. With both toxicants, limited centrilobular lesions were already present by the time DMSO was administered. Without treatment, liver injury rapidly progressed so that by 48 hr it occupied 40-50% of the liver, with accompanying large increases in plasma alanine aminotransferase (ALT) activity. Administration of DMSO greatly attenuated lesion development for both toxicants; the area injured was reduced by more than 4-fold, accompanied by a decrease in 48 hr ALT activity of 8-16-fold. The ability of DMSO to intervene in the development of liver injury at such a late time appears to be unique and may provide insight into therapies for acute xenobioticinduced hepatitis.

Key Words: Dimethyl sulfoxide • chloroform • bromobenzene • liver injury • rat • protection • pathology

Toxicologic Pathology, Vol. 27, No. 3, 342-347 (1999)
DOI: 10.1177/019262339902700310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. H. M. Heijne, A. L. Slitt, P. J. van Bladeren, J. P. Groten, C. D. Klaassen, R. H. Stierum, and B. van Ommen Bromobenzene-Induced Hepatotoxicity at the Transcriptome Level Toxicol. Sci., June 1, 2004; 79(2): 411 - 422. [Abstract] [Full Text] [PDF]

				D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-Gossmann, A. Atfi, F. Morel, H. Ichijo, and C. Guguen-Guillouzo Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation J. Biol. Chem., December 13, 2002; 277(51): 49220 - 49229. [Abstract] [Full Text] [PDF]